title: New drugs against tuberculosis: problems, progress, and evaluation of agents in clinical development.
authors.affiliation: Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands. jossyvandenboogaard@gmail.com
authors.forename: Jossy
authors.initials: J
authors.lastname: van den Boogaard
authors.forename: Gibson S
authors.initials: GS
authors.lastname: Kibiki
authors.forename: Elton R
authors.initials: ER
authors.lastname: Kisanga
authors.forename: Martin J
authors.initials: MJ
authors.lastname: Boeree
authors.forename: Rob E
authors.initials: RE
authors.lastname: Aarnoutse
mesh_terms: D000818:Animals; D000995:Antitubercular Agents / Q000493:pharmacokinetics* / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D024881:Drug Resistance, Bacterial; D024841:Fluoroquinolones / Q000009:adverse effects; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000235:genetics; D012294:Rifamycins / Q000493:pharmacokinetics / Q000494:pharmacology; D014376:Tuberculosis / Q000188:drug therapy* / Q000382:microbiology / Q000628:therapy*
chemical_list: D000995:Antitubercular Agents; D024841:Fluoroquinolones; D012294:Rifamycins